Global 3D printing for medical sector market was valued at US$ 412.2 million in 2015 and is expected to expand at a CAGR of 11.7% during the forecast period (2016 – 2024).

Seattle,WA, 2017-Aug-12 — /EPR Network/ — 

Global 3D Printing– Revolutionizing the Healthcare Industry

3D printing is revolutionizing the healthcare industry by providing improved therapy outcomes and affordable medical devices. This technology is enabling manufacturers to produce small and delicate parts of an organ or medical device with a high accuracy, which is a very cumbersome task using current manufacturing capabilities. Companies such as EnvisionTEC, Inc., 3D Systems, Inc., Stratasys Inc., Materialise NV, and Organovo Holdings, Inc. are collaborating with each other or independent research organizations and institutes to speed-up the research activities in order to decrease the time to market (TTM).

Request for the trending sample of this report: https://www.coherentmarketinsights.com/insight/request-sample/80

3D printing offers various benefits such as pre-operative planning of medical procedures based on the 3D model, creating anatomical models for training, creating medical products at lower costs, and possibility of manufacturing medical devices of smaller form factors with higher precision. Increasing awareness about cost benefits offered by this technology has increased its usage in hospitals, dentists, pharmaceutical companies, academic institutions, and medical clinics is propelling the market growth for 3D printing.

This report segments the global 3D printing for medical sector market on the basis of technology, application, and end user. On the basis of technology, the global 3D printing market is classified into electron beam melting, laser beam melting, droplet deposition and photopolymerization. Applications of 3D printing include tissue engineering, surgical implants, healthcare research and development (R&D), and others. 3D Printing technology is used for medical applications across pharmaceuticals and biotech companies, medical devices companies and academic and research institutions.

A plethora of medical applications 3D printing technology is primarily used to create artificial skin, kidney, liver, pancreas, pills, and orthopedic and dental implants. The current manufacturing capabilities are not adequate to produce artificial organs with precise shape and size of miniature organ parts. Biological models made from 3D printing technology can help in surgical training, planning, and offering personalized medicines, thus enhancing quality of life of the user. While the use of 3D printing is widely implemented in dental applications, other medical segments such as tissues, prosthetics, medicines and heart valves, medical equipment and synthetic skin are also expected to deploy 3D printing technology to a greater extent in the near future.

Different raw materials cater to different 3D printing demands

3D printing technology uses numerous materials such as the metals, ceramics, polymers, and biological cells for printing skin, organs, and medical devices. Metal printing is widely used in prosthetics and implants. Biological cells are widely used in skin and tissue printing. In 2014, L’Oreal S.A. announced partnership with Organovo Holdings, Inc. to 3D-print human skin. Organovo printed the first blood vessel in 2009 and is in the process of developing 3D-printed tissues through strategic partnerships with biopharmaceutical companies.

Ask for Request Customization @ https://www.coherentmarketinsights.com/insight/request-customization/80

Key features of the study:

  • This report provides in-depth analysis of 3D printing in medical sector and provides market size (US$ Million) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2016 – 2024), considering 2015 as the base year

  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market

  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players

  • It profiles leading players in the global 3D printing for medical sector market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies and future plans

  • Key companies covered as a part of this study include 3T RPD, Ltd., EnvisionTEC, Inc., Arcam AB, 3D Systems, Inc., Eos GmbH Electro Optical Systems, Renishaw plc, Stratasys Inc., Materialise NV, and Organovo Holdings, Inc.

Browse Global Strategic Business Report: https://www.coherentmarketinsights.com/market-insight/3d-printing-for-medical-sector-market-80

About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and Global 3D Printing Medical Sector Market,

3d printing healthcare market size,

3d printing medical devices market,competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

CONTACT US

Mr. Shah

Coherent Market Insights

1001 4th Ave,

#3200

Seattle, WA 98154

Tel : +1-206-701-6702

Email: sales@coherentmarketinsights.com

Website: https://www.coherentmarketinsights.com

Matched content

Editor’s Pick